Funding · Company
Convergent Therapeutics, Inc.
Cambridge, MABiotech & Pharma
Convergent Therapeutics, Inc. of Cambridge, MA has disclosed $51M across 2 Form D offerings filed with the SEC between May 22, 2023 and Aug 13, 2024.
$51M
Total disclosed
2
Form D offerings
2020
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$22M
Form D · Aug 13, 2024 ↗
Q3 2024
· target $40M
$29M
Form D · May 22, 2023 ↗
Q2 2023
· target $99M
Filing details
HeadquartersCambridge, MAIndustryBiotech & Pharma (Biotechnology)Incorporated2020SEC CIK0001978126Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →